Author

Bouchra Hassabi

Université Libre de Bruxelles

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Organism:mouse· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Emilie CalonneiD· 2 shared François FuksiD· 2 shared Margot Celerier· 2 shared Martin BizetiD· 2 shared Pascale Putmans· 2 shared Rachel Deplus· 2 shared Audrey PenningiD· 1 shared Bram BoeckxiD· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Emilie CalonneORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivPreprintJan 15, 2025

m3C is a mitochondrial mRNA modification which promotes tumor progression

Audrey Penning, Kun Wang, Margot Celerier…·François Fuks

This study identifies m3C as a novel mitochondrial mRNA modification catalyzed by METTL8, which promotes tumor progression by enhancing complex I activity and oncogenic pathways.

DOI 10.1101/2025.01.15.633161

humanmouse

𝕏 PostBluesky

Molecular BiologybioRxivPreprintJun 27, 2022

The RNA demethylase FTO controls m6A marking on SARS-CoV-2 and classifies COVID-19 severity in patients

Lionel Malbec, Margot Celerier, Martin Bizet…·François Fuks

This study shows that FTO affects m6A marking on SARS-CoV-2 RNA and correlates with COVID-19 severity in patients.

4 citations

humanmouse

𝕏 PostBluesky